228 related articles for article (PubMed ID: 6158493)
1. Studies on retinal neovascularization. Friedenwald Lecture.
Patz A
Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1133-8. PubMed ID: 6158493
[TBL] [Abstract][Full Text] [Related]
2. Observations on retinal neovascularization.
Patz A
Trans New Orleans Acad Ophthalmol; 1983; 31():82-8. PubMed ID: 6194596
[No Abstract] [Full Text] [Related]
3. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies.
Stefansson E; Landers MB; Wolbarsht ML
Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118
[TBL] [Abstract][Full Text] [Related]
4. [Proliferative retinopathy in experimental studies].
Prost M
Klin Oczna; 1985 Dec; 87(12):486-8. PubMed ID: 2423744
[No Abstract] [Full Text] [Related]
5. Oxygen-induced retinopathy in newborn kittens. A model for ischemic vasoproliferative retinopathy.
Kremer I; Kissun R; Nissenkorn I; Ben-Sira I; Garner A
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):126-30. PubMed ID: 2433248
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in ophthalmology. Retinal vascular diseases.
Patz A
N Engl J Med; 1978 Jun; 298(26):1451-4. PubMed ID: 349390
[No Abstract] [Full Text] [Related]
7. An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice.
Spierer A; Rabinowitz R; Pri-Chen S; Rosner M
Eye (Lond); 2005 Jan; 19(1):86-91. PubMed ID: 15232594
[TBL] [Abstract][Full Text] [Related]
8. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
Taomoto M; McLeod DS; Merges C; Lutty GA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
[TBL] [Abstract][Full Text] [Related]
9. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
Werdich XQ; McCollum GW; Rajaratnam VS; Penn JS
Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
[TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture.
Patz A
Am J Ophthalmol; 1982 Dec; 94(6):715-43. PubMed ID: 6184997
[TBL] [Abstract][Full Text] [Related]
11. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
12. [Retinopathy of prematurity: new perspectives on its pathogenesis].
Koerner F; Bossi E
Fortschr Ophthalmol; 1983; 80(4):294-7. PubMed ID: 6688794
[No Abstract] [Full Text] [Related]
13. Retrolental fibroplasia (retinopathy of prematurity).
Patz A
Trans Ophthalmol Soc N Z; 1980; 32():49-54. PubMed ID: 6934650
[No Abstract] [Full Text] [Related]
14. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
15. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
16. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
17. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
18. Retinopathy of prematurity: a new look at an old disease.
Wolbarsht ML; George GS; Shearin WA; Kylstra JA; Landers MB
Ophthalmic Surg; 1983 Nov; 14(11):919-24. PubMed ID: 6197686
[TBL] [Abstract][Full Text] [Related]
19. Pericytes and ocular diseases.
Motiejūnaite R; Kazlauskas A
Exp Eye Res; 2008 Feb; 86(2):171-7. PubMed ID: 18078933
[TBL] [Abstract][Full Text] [Related]
20. Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects.
Boulton ME; McLeod D; Garner A
Eye (Lond); 1988; 2 Suppl():S124-39. PubMed ID: 2474463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
